Compound Detail
CHEMBL2103774
TIBOLONE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C
Basic Information
| ChEMBL ID | CHEMBL2103774 |
| Name | TIBOLONE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | WZDGZWOAQTVYBX-XOINTXKNSA-N |
| Therapeutic | ✓ Yes |
5
Targets
9
Activities
2
Assay Types
0
PK Parameters
20
Publications
6
Known Names
5
Indications
Molecular Properties
312.4
MW (Da)
3.88
ALogP
2
HBA
1
HBD
37.3
PSA (Ų)
0.54
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Breast Neoplasms Menopause Osteoporosis Sexual Dysfunction, Physiological Depressive Disorder, Major
ATC Classification
G03CX01
tibolone
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
Activity Summary
IC50 5 meas. best 7.04
Ki 4 meas. best 7.54
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Progesterone receptor CHEMBL1909044 | Ki | 7.54 | 7.54 | 28.7 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 7.32 | 7.32 | 48.2 | 1 |
| Androgen receptor CHEMBL3072 | Ki | 7.12 | 7.12 | 75.4 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 7.04 | 7.04 | 90.7 | 1 |
| Androgen receptor CHEMBL3072 | IC50 | 6.95 | 6.95 | 113.0 | 1 |
| Estrogen receptor CHEMBL206 | Ki | 6.91 | 6.91 | 123.8 | 1 |
| Progesterone receptor CHEMBL1909044 | IC50 | 6.66 | 6.66 | 219.7 | 1 |
| Estrogen receptor CHEMBL206 | IC50 | 6.36 | 6.36 | 433.3 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 5.52 | 5.52 | 3000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 926114 | 10.1021/jm00219a006 | Progesterone receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| - | 10.6019/CHEMBL4513141 | Acinetobacter baumannii | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-dependent L-type calcium channel subunit alpha-1C | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| - | 10.6019/CHEMBL4513141 | Staphylococcus aureus | 1 |
| - | 10.6019/CHEMBL4513141 | Klebsiella pneumoniae | 1 |
| - | 10.6019/CHEMBL4513141 | Escherichia coli | 1 |
| - | 10.6019/CHEMBL4513141 | Candida albicans | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| 38318365 | 10.1016/j.isci.2024.108907 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 1 |
Data from ChEMBL 36 via Core Engine